Skip to main content

IceCure Medical Ltd.

corporate_fare Company Profile

IceCure Medical Ltd.

ICCM·NASDAQ·Industrial Applications And Services·CIK 0001584371

We are a commercial-stage medical device company that researches and develops cryoablation systems and disposable products using liquid nitrogen (LN2) to treat tumors. Cryoablation is a process that destroys benign and malignant tumors, nerves, or other tissues by freezing them inside a patient's body. Our cryoablation technology offers a minimally invasive alternative to surgery for tumors in areas like the breast, lungs, kidneys, bones, and other tissues. It is also used for nerve ablation to manage pain and treat conditions such as endometriosis. Our main commercial cryoablation product is the ProSense system and its associated CryoProbes. The FDA has authorized the ProSense system for marketing for the local treatment of low-risk breast cancer, when combined with adjuvant endocrine therapy, in women aged 70 and above, including those unsuitable for surgical alternatives. We are also developing new products, including the XSense system with CryoProbes, which has received 510(k) regulatory clearance from the FDA. We believe the XSense system can serve as a platform for developing other unique CryoProbes and catheters, expanding our clinical applications. Our product pipeline also includes MSense, which could enable the treatment of multiple and larger tumors.

IceCure Medical Ltd. (NASDAQ:ICCM) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 48 items for ICCM at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • IceCure Medical confirms reverse split as key to Nasdaq compliance, capital strategy
  • IceCure's ProSense® Shows Strong Kidney Cancer Efficacy, Drives Breast Cryoablation Interest at ECIO 2026
  • IceCure Medical Receives 180-Day Nasdaq Extension to Regain Minimum Bid Price Compliance
  • Nasdaq Grants IceCure 180-Day Extension for Bid Price Compliance
  • IceCure Medical Launches New $4.34M At-The-Market Offering

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$3.38M
Net Income
-$15.06M
Diluted EPS
$0.24
Op. Cash Flow
-$14.57M
Free Cash Flow
-$14.61M
Gross Profit
$1.23M
Operating Income
-$15.09M
Cash & Equivalents
$8.9M
Total Debt
$13K
Debt / Equity
0.00×
Net Margin
-445.6%
Shares Outstanding
73.12M sh
Source: 20-F · filed 2026-03-17 · accession 0001213900-26-028684

Insider Transactions

ICCM files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

$0.9203 -7.70% today
52-week range · as of 2026-11-18 $0.65 – $22.5
Market cap
$4.45M
Volume
202.7K (0.9× avg)
3-mo avg 215.9K
Live data · 2026-11-22 12:47 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ICCM - Filings & News (Page 2)

ICCM
Jun 02, 2026, 8:31 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.180
Real-time Price: $0.9203 info
Change: Reverse Stock Split info
Market Cap: $4.454M info
ICCM
May 19, 2026, 8:45 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.225
Real-time Price: $0.9203 info
Change: Reverse Stock Split info
Market Cap: $4.454M info
ICCM
May 13, 2026, 5:00 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.2489
Real-time Price: $0.9203 info
Change: Reverse Stock Split info
Market Cap: $4.454M info
ICCM
May 13, 2026, 4:30 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $0.240
Real-time Price: $0.9203 info
Change: Reverse Stock Split info
Market Cap: $4.454M info
ICCM
May 12, 2026, 5:05 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $0.245
Real-time Price: $0.9203 info
Change: Reverse Stock Split info
Market Cap: $4.454M info
ICCM
May 12, 2026, 4:11 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.240
Real-time Price: $0.9203 info
Change: Reverse Stock Split info
Market Cap: $4.454M info
ICCM
May 12, 2026, 9:28 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.230
Real-time Price: $0.9203 info
Change: Reverse Stock Split info
Market Cap: $4.454M info
ICCM
May 12, 2026, 8:30 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $0.2331
Real-time Price: $0.9203 info
Change: Reverse Stock Split info
Market Cap: $4.454M info
ICCM
May 06, 2026, 4:29 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.2789
Real-time Price: $0.9203 info
Change: Reverse Stock Split info
Market Cap: $4.454M info
ICCM
Apr 22, 2026, 5:28 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.3574
Real-time Price: $0.9203 info
Change: Reverse Stock Split info
Market Cap: $4.454M info
ICCM
Apr 21, 2026, 8:45 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.3587
Real-time Price: $0.9203 info
Change: Reverse Stock Split info
Market Cap: $4.454M info
ICCM
Apr 01, 2026, 4:30 PM EDT
Filing Type: F-1
Importance Score:
8
Price at Filing: $0.310
Real-time Price: $0.9203 info
Change: Reverse Stock Split info
Market Cap: $4.454M info
ICCM
Mar 27, 2026, 8:49 AM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $0.3762
Real-time Price: $0.9203 info
Change: Reverse Stock Split info
Market Cap: $4.454M info
ICCM
Mar 27, 2026, 6:13 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.417
Real-time Price: $0.9203 info
Change: Reverse Stock Split info
Market Cap: $4.454M info
ICCM
Mar 27, 2026, 6:11 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.417
Real-time Price: $0.9203 info
Change: Reverse Stock Split info
Market Cap: $4.454M info
ICCM
Mar 25, 2026, 8:45 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.6397
Real-time Price: $0.9203 info
Change: Reverse Stock Split info
Market Cap: $4.454M info
ICCM
Mar 24, 2026, 8:45 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.6699
Real-time Price: $0.9203 info
Change: Reverse Stock Split info
Market Cap: $4.454M info
ICCM
Mar 20, 2026, 4:02 PM EDT
Filing Type: F-3/A
Importance Score:
9
Price at Filing: $0.6151
Real-time Price: $0.9203 info
Change: Reverse Stock Split info
Market Cap: $4.454M info
ICCM
Mar 17, 2026, 9:03 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.705
Real-time Price: $0.9203 info
Change: Reverse Stock Split info
Market Cap: $4.454M info
ICCM
Mar 17, 2026, 8:44 AM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $0.7002
Real-time Price: $0.9203 info
Change: Reverse Stock Split info
Market Cap: $4.454M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets